Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Orchestra BioMed Holdings, Inc. - Ordinary Shares
(NQ:
OBIO
)
7.380
+0.380 (+5.43%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
69,992
Open
7.150
Bid (Size)
7.020 (1)
Ask (Size)
11.37 (5)
Prev. Close
7.000
Today's Range
6.752 - 7.620
52wk Range
4.220 - 11.69
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board of Directors
July 30, 2024
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
Precision Neuroscience Expands Executive Team as Brain–Computer Interface Industry Rapidly Advances
July 23, 2024
Jayme Strauss and Mike Kaswan join as Chief Clinical and Commercial Officer and Chief Financial Officer, respectively, as the company progresses toward FDA clearance
From
Precision Neuroscience
Via
GlobeNewswire
Performance
YTD
-15.95%
-15.95%
1 Month
+3.65%
+3.65%
3 Month
+67.73%
+67.73%
6 Month
+4.24%
+4.24%
1 Year
+34.18%
+34.18%
More News
Read More
Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024
June 04, 2024
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
Orchestra BioMed to Participate in Jefferies Global Healthcare Conference
May 22, 2024
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
OBIO Stock Earnings: Orchestra BioMed Hldgs Beats EPS, Misses Revenue for Q1 2024
May 13, 2024
Via
InvestorPlace
Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
May 13, 2024
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
May 02, 2024
Via
Benzinga
Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents
April 30, 2024
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024
April 30, 2024
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
OBIO Stock Earnings: Orchestra BioMed Hldgs Beats EPS, Misses Revenue for Q4 2023
March 27, 2024
Via
InvestorPlace
Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
March 27, 2024
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors
March 26, 2024
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting
March 13, 2024
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
Orchestra BioMed to Participate in Upcoming Investor Conferences
March 07, 2024
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients
March 06, 2024
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy for Over 3 Years
February 26, 2024
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
Orchestra BioMed Reports Third Quarter 2023 Financial Results and Provides Business Update
November 13, 2023
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
Top 4 Health Care Stocks That Should Keep You Up At Night
September 21, 2023
Via
Benzinga
Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
September 20, 2023
Via
Benzinga
Why Terran Orbital Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 19, 2023
Via
Benzinga
Why Shares of Orchestra BioMed Jumped Tuesday
September 19, 2023
Via
The Motley Fool
Exposures
Product Safety
Crude Oil Rises Over 1%; Revance Therapeutics Shares Plummet
September 19, 2023
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Orchestra BioMed, Vital Farms And Other Big Stocks Moving Higher On Tuesday
September 19, 2023
Via
Benzinga
Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for the Treatment of Hypertension in Pacemaker Patients
September 19, 2023
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
September 15, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
